Yuchun Lee - 04 Apr 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
04 Apr 2022
Net transactions value
-$1,080,424
Form type
4
Filing time
06 Apr 2022, 16:59:58 UTC
Next filing
08 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $163,080 +2,000 +107% $81.54 3,875 04 Apr 2022 Direct
transaction VRTX Common Stock Sale $26,583 -100 -2.6% $265.83 3,775 04 Apr 2022 Direct F1
transaction VRTX Common Stock Sale $245,050 -917 -24% $267.23 2,858 04 Apr 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $263,798 -983 -34% $268.36 1,875 04 Apr 2022 Direct F1, F2, F4
transaction VRTX Common Stock Options Exercise $163,080 +2,000 +107% $81.54 3,875 05 Apr 2022 Direct
transaction VRTX Common Stock Sale $4,561 -17 -0.44% $268.30 3,858 05 Apr 2022 Direct F1
transaction VRTX Common Stock Sale $90,197 -334 -8.7% $270.05 3,524 05 Apr 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $132,707 -488 -14% $271.94 3,036 05 Apr 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $163,560 -600 -20% $272.60 2,436 05 Apr 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale $27,350 -100 -4.1% $273.50 2,336 05 Apr 2022 Direct F1
transaction VRTX Common Stock Sale $126,618 -461 -20% $274.66 1,875 05 Apr 2022 Direct F1, F2, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $163,080 -2,000 -10% $81.54 18,000 04 Apr 2022 Common Stock 2,000 $81.54 Direct F9
transaction VRTX Stock Option (Right to Buy) Options Exercise $163,080 -2,000 -11% $81.54 16,000 05 Apr 2022 Common Stock 2,000 $81.54 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $267.23 (range $266.85 to $267.79).
F4 Open market sales reported on this line occurred at a weighted average price of $268.36 (range $267.97 to $268.81).
F5 Open market sales reported on this line occurred at a weighted average price of $270.05 (range $269.79 to $270.64).
F6 Open market sales reported on this line occurred at a weighted average price of $271.94 (range $271.35 to $272.27).
F7 Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.36 to $273.34).
F8 Open market sales reported on this line occurred at a weighted average price of $274.66 (range $274.63 to $274.68).
F9 Fully vested.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney